Results 101 to 110 of about 9,761 (163)

A bivalent inactivated influenza vaccine incorporating epitope-optimized surface proteins confers cross-protective immunity against H9N2 influenza virus. [PDF]

Emerg Microbes Infect
Hao M, Guan Y, Xu M, Yang W, Wang Y, Zhang Y, Chen J.   +6 more
europepmc   +1 more source

Genetic evolution, phylodynamics, geographic spread of H9N2 avian influenza viruses in China from 2014 to 2025: an increasing potential zoonotic risk. [PDF]

Emerg Microbes Infect
Pang Z, Zhong P, Mai C, Fan J, Wu Y, Zhang Y, Liu H, Sun H, Liao M, Sun H.   +9 more
europepmc   +1 more source

Genetic Diversity, Reassortment Patterns, and Antigenic Characterization of Two H9N2 Avian Influenza Viruses Isolated from Quails in China. [PDF]

Viruses
Teng Y, Li P, Zhang F, Zhou W, Wang X, Zhu H, Song Q, Li Z, Liu C.   +8 more
europepmc   +1 more source

Genetic and Pathogenicity Studies of Avian Influenza (H9N2) Virus Isolated from Chickens in Jiangsu Province, China, in 2025. [PDF]

Microorganisms
Li Y, Song X, Gao T, Wang G, Wei H, Wang J, Jiang W, Zhang R, Meng Y, Jiang S.   +9 more
europepmc   +1 more source

Novel emerging reassortant H6 avian influenza viruses with internal genes from G57 genotype of H9N2 pose potential zoonotic risk. [PDF]

Emerg Microbes Infect
Wan Z, Jiang W, Cao X, Guo X, He X, Zhang J, Chu X, Ji X, Liu Y, Yin X, Zhao Z, Wang J, Gao W, Xie Q, Li T, Shao H, Qin A, Bi Y, Ye J.   +18 more
europepmc   +1 more source

Molecular epidemiological characteristics of H9N2 subtype avian influenza virus in the external environment of western Zhejiang, China, 2014-2025. [PDF]

Front Public Health
Huang S, Zhan B, Wang M, Lyu L, You J, Yang R, Yang H.   +6 more
europepmc   +1 more source

RETRACTED: Ren et al. Glycine Nano-Selenium Enhances Immunoglobulin and Cytokine Production in Mice Immunized with H9N2 Avian Influenza Virus Vaccine. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 7914. [PDF]

Int J Mol Sci
Ren Z, Okyere SK, Zhang M, Zhang X, He H, Hu Y.   +5 more
europepmc   +1 more source

Novel Reassortant H9N2 Avian Influenza Viruses with Dual Receptor-Binding Capacity and Evidence of Direct Mammalian Infectivity Circulating in Northeast China Live Poultry Markets. [PDF]

Viruses
Ren Y, Li H, Yan W, Liu X, Chi W, Luo R, Stoeger T, Wajid A, Dodovski A, Gao C, Wang G, Lusida MI, Mingala CN, Andreychuk DB, Yin R.   +14 more
europepmc   +1 more source

A neuraminidase-targeting nanobody as a therapeutic candidate against influenza A and B viruses. [PDF]

J Virol
Liu D, Zhang Y, Zhang M, Guo R, Peng W, Cao R, Yang X, Chen J, Huang S, Li J, Sheng C, Qin L.   +11 more
europepmc   +1 more source

ATG13 promotes K63-linked polyubiquitination of MAVS via ASB1 to restrict influenza A virus replication. [PDF]

Emerg Microbes Infect
Lu Y, Chen J, Xiao H, Li J, Wang H, Liang T, Wang J, Pang X, Cheng M, Sun Y, Cui T, Pu F, Zhan J, Zhao Y, Bao H, Yang W, Jiang Y, Yang G, Wang J, Cao X, Wang C, Bai X, Zeng Y.   +22 more
europepmc   +1 more source